Overview

Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions